The use of good quality immunogenic compositions in pre-clinical immunogenicity and efficacy studies are necessary to generate high quality data. Recognizing that access to quality adjuvants, formulations and the know how to make immunogenic compositions is not widely available, the foundation is supporting partners to provide these resources and expertise to foundation grantees and collaborators.
© 2021 Bill & Melinda Gates Foundation. All Rights Reserved.
Privacy & Cookies Notice |